Tri Chemical Half-Year Profit Rises 22% on AI Data-Centre Demand as Taiwan Sales Jump 37%

Net sales rose 18.8% to ¥14,705 million and operating profit 20.8% to ¥3,838 million, widening the operating margin to 26.1%. Net profit rose 21.5% to ¥3,373 million. Sales to Taiwan rose 36.9% and to China 25.5%, while Japan and Korea both edged down.

Tri Chemical Laboratories Inc. H1 FY1/2027 earnings summary

A supplier of the chemicals that get deposited on a wafer

Tri Chemical Laboratories Inc. (TSE: 4369) published consolidated results for the six months to July 31, 2026 on August 31, 2026 under Japanese GAAP. Net sales rose 18.8% to ¥14,705 million, operating profit 20.8% to ¥3,838 million, ordinary profit 19.1% to ¥4,526 million and net profit 21.5% to ¥3,373 million, for earnings per share of ¥103.81 against ¥85.45.

The company makes high-purity chemical compounds for semiconductor manufacturing and runs the business as a single segment. It describes the end market plainly: consumer demand such as smartphones still lacks strength, but data-centre investment tied to the spread of generative AI and capital appetite centred on leading-edge logic and memory have held firm, and demand for high-purity compounds has risen with them.

The operating margin widened to 26.1% from 25.7% — profit grew slightly faster than sales despite raw-material and energy costs, which the company met with company-wide cost reduction, selling-price revisions and closer coordination between group companies and divisions. Ordinary profit again exceeded operating profit, by ¥688 million against ¥623 million a year earlier, chiefly through equity-method income from the Korean affiliate SK Tri Chem Co., Ltd.

Where the growth came from

The geographic split is uneven in a way worth noting. Taiwan rose 36.9% to ¥4,950 million and China 25.5% to ¥5,841 million — together ¥2,520 million of the ¥2,330 million total increase, meaning the two more than accounted for all of it. Japan slipped 0.5% to ¥2,206 million, South Korea 2.1% to ¥1,276 million and other regions 25.8% to ¥433 million. Greater China now takes 73.3% of sales against 66.8% a year earlier.

By application, the two largest lines both grew strongly: High-k materials rose 17.3% to ¥7,132 million and metal materials 36.9% to ¥3,198 million. Etching materials were nearly flat at ¥1,870 million (+2.6%), other silicon-semiconductor uses rose 31.4% to ¥1,997 million, and non-silicon applications fell 17.1% to ¥509 million. On capacity, the company continues to build out the production system at its Minami-Alps site, the base for new etching materials, and to strengthen production and quality control for new AI-related materials.

Balance sheet, guidance and dividend

Total assets rose 3.9% from the January year-end to ¥49,121 million. Current assets grew ¥1,191 million on higher cash, and fixed assets ¥655 million as equity-method income lifted investment securities. Current liabilities fell ¥2,015 million while fixed liabilities rose ¥1,761 million on higher long-term borrowings — a maturity shift rather than a change in leverage. Net assets rose 5.8% to ¥38,249 million and the equity ratio improved to 77.9% from 76.5%.

Full-year FY1/2027 guidance was revised, announced separately the same day alongside the variance between first-half guidance and actuals. It now stands at net sales of ¥29,500 million (+23.5%), operating profit of ¥7,450 million (+26.2%), ordinary profit of ¥8,720 million (+23.0%) and net profit of ¥6,570 million (+19.1%), for earnings per share of ¥202.17. The half therefore represents 51.5% of the full-year operating-profit target on 49.8% of the sales target. The annual dividend is held at ¥35.00, paid entirely at year-end with no interim.

Tri Chemical Laboratories Inc. — H1 FY1/2027 (February 1 – July 31, 2026), Japanese GAAP, consolidated. Balance-sheet rows compare July 31, 2026 with January 31, 2026; guidance and dividend rows are full-year FY1/2027 against FY1/2026. "—" indicates a figure not disclosed.
MetricH1 FY1/2027H1 FY1/2026Change
Net sales (¥ million)14,70512,375+18.8%
Operating profit (¥ million)3,8383,177+20.8%
Operating margin26.1%25.7%+0.4 pt
Ordinary profit (¥ million)4,5263,800+19.1%
Net profit (¥ million)3,3732,776+21.5%
EPS (¥)103.8185.45+21.5%
Japan — revenue (¥ million)2,2062,217−0.5%
China — revenue (¥ million)5,8414,654+25.5%
Taiwan — revenue (¥ million)4,9503,616+36.9%
South Korea — revenue (¥ million)1,2761,304−2.1%
Other regions — revenue (¥ million)433584−25.8%
Total assets (¥ million)49,12147,274+3.9%
Net assets (¥ million)38,24936,149+5.8%
Equity ratio77.9%76.5%+1.4 pt
FY1/2027 guidance — revenue (¥ million)29,500+23.5%
FY1/2027 guidance — operating profit (¥ million)7,450+26.2%
FY1/2027 guidance — ordinary profit (¥ million)8,720+23.0%
FY1/2027 guidance — net profit (¥ million)6,570+19.1%
FY1/2027 guidance — EPS (¥)202.17n.m.
Annual dividend per share (¥)35.0035.00unchanged

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.